Transperineal biopsies of MRI-detected aggressive index lesions in low-Â and intermediate-risk prostate cancer patients: Implications for treatment decision

MpMRI-US fusion-targeted biopsy sampling allows detection and characterization of otherwise undetected aggressive disease, often placing men in higher risk groups and altering the treatment approach.